Peer-influenced content. Sources you trust. No registration required. This is HCN.
Physician’s Weekly
Mean adjusted adult BMI was significantly higher among individuals with childhood ADHD compared with controls, with the highest BMI observed in those treated with MPH for ≥365 days.
Family Medicine/General Practice January 28th 2026
Conexiant
The FDA concluded that GLP-1 RA medications are not associated with suicidal ideation or behavior and is requesting corresponding updates to product labeling.
Endocrinology, Diabetes, Metabolism January 27th 2026
MedCentral
“A patient who has VCID as the major cause of their dementia alongside some suspicion of an alternate neurodegenerative cause may not benefit from [anti-AD] medications as much as one who only has signs of neurodegeneration and no VCID.” – Tanav Popli, MD
Cardiology January 22nd 2026
Neurology Learning Network
Benjamin Tolchin, MD and lead authors of the study remarked: “Most people with functional seizures do not receive targeted and evidence-based treatment, contributing to ongoing functional seizures and disability.”
Neurology January 22nd 2026
Epoch Health
“Patients and doctors [lack] enough research to inform medical guidelines and many patients are using these products without talking to their doctor about them.” —Senior White House official
Family Medicine/General Practice January 21st 2026
Psychiatrist.com
The historical use of classic monoamine oxidase inhibitors (MAOIs) is overviewed, with consideration given to their efficacy and safety before discussing the importance of reassessing their place in current treatment algorithms.
Psychiatry January 21st 2026